DE450184C - Process for making urethanes - Google Patents

Process for making urethanes

Info

Publication number
DE450184C
DE450184C DEC36278D DEC0036278D DE450184C DE 450184 C DE450184 C DE 450184C DE C36278 D DEC36278 D DE C36278D DE C0036278 D DEC0036278 D DE C0036278D DE 450184 C DE450184 C DE 450184C
Authority
DE
Germany
Prior art keywords
acid
urethanes
phenols
amino acids
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEC36278D
Other languages
German (de)
Inventor
Dr Dielrich Lammering
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemische Fabrik Von Heyden AG
Original Assignee
Chemische Fabrik Von Heyden AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemische Fabrik Von Heyden AG filed Critical Chemische Fabrik Von Heyden AG
Priority to DEC36278D priority Critical patent/DE450184C/en
Application granted granted Critical
Publication of DE450184C publication Critical patent/DE450184C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/02Preparation of esters of carbonic or haloformic acids from phosgene or haloformates

Description

Verfahren zur Herstellung-,von Urethanen. Es wurde .gefunden, daß Phenole dadurch in eine therapeutisch verwendbare Form übergeführt werden können, daß man aus ihnen die Urethane mit Aminosäuren darstellt. Man erhält sie, indem man die Phenole in üblicher Weise in die Phenoikohlensäurechloride verwandelt und- die letzteren auf Aminosäuren zur Einwirkung bringt, wobei man zweckmäßig die frei werdende Salzsäure durch die entsprechenden Mengen Alkalien, Erdalkalien, tertiäre Basen o. dgl. bindet. Die Vertreter -dieser Körperklasse sind sch3ver lösliche, geschmacklose Substanzen. In Alkalien lösen- sie sich zunächst leicht unter Salzbildung auf, verseifen aber bald mit bemerkenswerter Leichtigkeit, indem sie in Phenol, aminosaures Salz und Kohlensäure zerfallen.Process for the production, of urethanes. It was found that Phenols can thereby be converted into a form that can be used therapeutically, that one represents the urethanes with amino acids from them. It is obtained by the phenols are converted into the phenolic acid chlorides in the usual way and- brings the latter to action on amino acids, expediently freeing them resulting hydrochloric acid with the appropriate amounts of alkalis, alkaline earths, tertiary Bases or the like binds. The representatives of this body class are highly soluble, tasteless substances. In alkalis they initially dissolve easily with salt formation but soon saponify with remarkable ease by converting them to phenol, amino acid salt and carbonic acid break down.

Es ist zwar bereits bekannt, durch Umsetzei von Chlorkohlensäuremethylester mit Anthranilsäure das entsprechende Urethan herzustellen. Die Gewinnung von Urethanen aus Phenolen und Aminosäuren ist aber von besonderer )Vichtigkeit, weil sich dadurch neue Anwendungsmöglichkeiten der Phenole in der Medizin ergeben. So ist das in nachstehendem Beispiel erwähnte Tetrahydronaphthol ein sehr brauchbares Wurmmittel. Es läßt sich aber wegen seiner ätzenden Eigenschaften nicht unmittelbar per os anwenden. Bringt man es dagegen in Esterform, so sind diese Ester entweder zu schwer verseifbar oder verteilen sich nicht genügend in dem alkalischen Darmsaft. Durch Überführen des Tetrahydronaphthols in den Chlorkohlensäureester und Umsetzen desselben mit Anthranilsäure erhält man dagegen eine Verbindung, welche sich einesteils im alkalischen Darmsaft vollkommen auflöst und dadurch gleichmäßig verteilt wird, andererseits in dieser feinen Verteilung sehr schnell der Verseifung unterliegt, wodurch das wirksame Tetrahy dronaphthol in völlig gleichmäßiger Verteilung dort zur Wirkung kommt, wo die Parasiten hauptsächlich auftreten. Durch das vorliegende Verfahren wird also eine sehr wichtige Aufgabe der Therapie- gelöst. Beispiel. In eine Lösung von i 2o g Phosgen in 6oo ä Benzol tropft man unter Kühlen eine Lösung von 148 g Tetrahydro-[3-naphtliol in 121 g Dimethylanilin und i oo g Benzol. Nach z¢ Stunden wird das gebildete salzsaure Dimethylanilin durch Ausschütteln mit eisgekühlter verdünnter Salzsäure entfernt. Zu der benzolischen Lösung von i Mol. Tetraloll:ohlensäurechlorid, wie sie so erhalten wird, fügt man nun unter Rühren und Kühlen i Mol. fein gepulverte Anthranilsäure. Nach mehreren Stunden ist ein Teil der Anthranilsäure in das Urethan übergeführt, während der andere Teil die bei der Reaktion entstehende Salzsäure aufgenommen hat. Durch allmähliches Zufügen von i Mol. Alkali, z. B. in Form von Natronlauge, wird auch der zweite Teil der Anthranilsäure in das Urethan übergeführt. Der entstehende Brei von Tetralolanthranilsäureurethan wird durch Filtration von dem Benzol-Z`'asser-Gemisch getrennt. Aus Alkohol erhält man die Substanz rein. Sie hat die Fonnel: Schipp. 175°. Die Verbindung ist sehr schwer löslich in Wasser, leichter in Alkohol, Aceton 3... und Chloroform. In Alkalien löst sie sich unter Salzbildung auf.It is already known to produce the corresponding urethane by reacting methyl chlorocarbonate with anthranilic acid. The extraction of urethanes from phenols and amino acids is of particular importance because it opens up new possibilities for the use of phenols in medicine. Thus, the tetrahydronaphthol mentioned in the example below is a very useful wormer. However, due to its caustic properties, it cannot be used directly orally. If, on the other hand, it is brought into ester form, these esters are either too difficult to saponify or do not distribute sufficiently in the alkaline intestinal juice. By converting the tetrahydronaphthol into the chlorocarbonic acid ester and reacting it with anthranilic acid, on the other hand, a compound is obtained which on the one hand completely dissolves in the alkaline intestinal juice and is thus evenly distributed, and on the other hand is very quickly subject to saponification in this fine distribution, whereby the effective tetrahydronaphthol is completely uniform distribution takes effect where the parasites mainly occur. The present method thus solves a very important task of therapy. Example. A solution of 148 g of tetrahydro [3-naphthiol in 121 g of dimethylaniline and 100 g of benzene is added dropwise to a solution of 12o g of phosgene in 600 Å of benzene, while cooling. After two hours, the hydrochloric acid dimethylaniline formed is removed by shaking with ice-cold dilute hydrochloric acid. One mole of finely powdered anthranilic acid is then added to the benzene solution of 1 mol. After several hours, part of the anthranilic acid has been converted into the urethane, while the other part has absorbed the hydrochloric acid formed during the reaction. By gradually adding 1 mole of alkali, e.g. B. in the form of sodium hydroxide solution, the second part of the anthranilic acid is also converted into the urethane. The resulting paste of tetralolanthranilic acid urethane is separated from the benzene-water mixture by filtration. The substance is obtained pure from alcohol. It has the formula: Schipp. 175 °. The compound is very sparingly soluble in water, more easily in alcohol, acetone 3 ... and chloroform. In alkalis it dissolves with salt formation.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von Urethanen aus Phenolen und Amin-osäuren, dadurch gekennzeichnet, daB man Phenolkohlensäurechloride mit Aminosäuren umsetzt.PATENT CLAIM: Process for the production of urethanes from phenols and amino acids, characterized in that phenolic acid chlorides are used with Converts amino acids.
DEC36278D 1925-02-24 1925-02-24 Process for making urethanes Expired DE450184C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEC36278D DE450184C (en) 1925-02-24 1925-02-24 Process for making urethanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEC36278D DE450184C (en) 1925-02-24 1925-02-24 Process for making urethanes

Publications (1)

Publication Number Publication Date
DE450184C true DE450184C (en) 1927-10-01

Family

ID=7022207

Family Applications (1)

Application Number Title Priority Date Filing Date
DEC36278D Expired DE450184C (en) 1925-02-24 1925-02-24 Process for making urethanes

Country Status (1)

Country Link
DE (1) DE450184C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2933383A (en) * 1956-11-23 1960-04-19 Union Carbide Corp Method of combating weeds using nu-substituted carbamates of 2, 4, 5-trichloro, 6-nitro phenol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2933383A (en) * 1956-11-23 1960-04-19 Union Carbide Corp Method of combating weeds using nu-substituted carbamates of 2, 4, 5-trichloro, 6-nitro phenol

Similar Documents

Publication Publication Date Title
DE450184C (en) Process for making urethanes
DE668742C (en) Process for the preparation of 2-phenylquinoline-4-carboxylic acids containing iodine and oxy groups
DE457060C (en) Process for the preparation of ar-tetrahydro-ª ‰ -naphthol derivatives
DE424749C (en) Process for the manufacture of preparations for inhalation purposes
DE338735C (en) Process for the preparation of complex iron compounds of phosphoric acid esters of higher aliphatic polyhydroxyl compounds
DE411956C (en) Process for the production of soluble acidic calcium or calcium-magnesium salts of inositol phosphoric acid
DE576445C (en) Process for the production of primula acid (primula saponin) from primula species
DE346889C (en) Process for the preparation of mixed carbonic acid esters of china alkaloids
DE707593C (en) Process for producing genuine crystallized cardiac active glucosides from Digitalis Ianata
DE608667C (en) Process for the preparation of water-soluble zinc compounds of oxymethanesulfinic acid
DE533470C (en) Process for the preparation of dinaphthocarbazole sulfonic acids and their corresponding oxy compounds
DE578941C (en) Process for the preparation of santonin derivatives
DE558567C (en) Process for the production of soluble particles of organic antimony compounds
DE579147C (en) Process for the production of easily soluble salts of bile acids
DE604920C (en) Process for the preparation of cyclic 1,2-aminoketones
DE398406C (en) Process for the production of aluminum formate solutions
DE880303C (en) Process for the production of a crystallized penicillin salt which is sparingly soluble in water
DE671280C (en) Process for the production of quinine compounds with little or no taste
AT117475B (en) Process for the preparation of substitution products of ß-iodopyridine.
DE173240C (en)
DE515468C (en) Process for the preparation of ª ‰ -Naphthylaminophenoxyfettsaeuren
DE557519C (en) Process for the preparation of easily soluble alkali salts of acylaminophenolar acids
DE762123C (en) Process for the production of physiologically active compounds of 2-alkyl-1,4-naphthoquinone or hydroquinone
DE852245C (en) Process for the preparation of bis (diacetyl) tartryl diphenolisatin
DE564434C (en) Process for the preparation of crystallized d-glycic acid